An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
Adams W, Ayton S, van den Buuse M.Adams W, et al. Among authors: van den buuse m.Psychopharmacology (Berl). 2009 Nov;206(4):665-76. doi: 10.1007/s00213-009-1617-1. Epub 2009 Jul 23.Psychopharmacology (Berl). 2009.PMID: 19629448
Kusljic S, Copolov DL, van den Buuse M.Kusljic S, et al. Among authors: van den buuse m.Neuropsychopharmacology. 2003 Dec;28(12):2138-47. doi: 10.1038/sj.npp.1300277.Neuropsychopharmacology. 2003.PMID: 12888784
van den Buuse M, Morris M, Chavez C, Martin S, Wang J.van den Buuse M, et al.Br J Pharmacol. 2004 Jun;142(3):543-50. doi: 10.1038/sj.bjp.0705511. Epub 2004 May 17.Br J Pharmacol. 2004.PMID: 15148266Free PMC article.
Kusljic S, van den Buuse M.Kusljic S, et al. Among authors: van den buuse m.Eur J Neurosci. 2004 Dec;20(12):3424-32. doi: 10.1111/j.1460-9568.2004.03804.x.Eur J Neurosci. 2004.PMID: 15610175
Kusljic S, Brosda J, Norman TR, van den Buuse M.Kusljic S, et al. Among authors: van den buuse m.Brain Res. 2005 Jul 12;1049(2):217-26. doi: 10.1016/j.brainres.2005.05.017.Brain Res. 2005.PMID: 15953591
We have previously shown that brain serotonin depletion by lesions of the median raphe nucleus (MRN) causes enhancement of phencyclidine-induced locomotor hyperactivity [S. Kusljic, D.L. Copolov, M. vandenBuuse, Differential role of serotonergic proj …
We have previously shown that brain serotonin depletion by lesions of the median raphe nucleus (MRN) causes enhancement of phencyclidine-ind …
van den Buuse M, Garner B, Gogos A, Kusljic S.van den Buuse M, et al.Aust N Z J Psychiatry. 2005 Jul;39(7):550-7. doi: 10.1080/j.1440-1614.2005.01626.x.Aust N Z J Psychiatry. 2005.PMID: 15996135Review.
van den Buuse M, Martin S, Brosda J, Leck KJ, Matthaei KI, Hendry I.van den Buuse M, et al.Psychopharmacology (Berl). 2005 Dec;183(3):358-67. doi: 10.1007/s00213-005-0181-6. Epub 2005 Oct 12.Psychopharmacology (Berl). 2005.PMID: 16220329
Kusljic S, van den Buuse M.Kusljic S, et al. Among authors: van den buuse m.Behav Brain Res. 2006 Mar 15;168(1):74-82. doi: 10.1016/j.bbr.2005.10.013. Epub 2005 Nov 21.Behav Brain Res. 2006.PMID: 16303186
Kusljic S, Brosda J, van den Buuse M.Kusljic S, et al. Among authors: van den buuse m.Br J Pharmacol. 2006 Apr;147(7):800-7. doi: 10.1038/sj.bjp.0706641.Br J Pharmacol. 2006.PMID: 16415909Free PMC article.
Gogos A, Martin S, Jones ME, van den Buuse M.Gogos A, et al. Among authors: van den buuse m.Psychopharmacology (Berl). 2006 Sep;188(1):100-10. doi: 10.1007/s00213-006-0472-6. Epub 2006 Aug 1.Psychopharmacology (Berl). 2006.PMID: 16896955